Title
BioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRC
Go Home
Category
Description
BioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRC
Address
Phone Number
+1 609-831-2326 (US) | Message me
Site Icon
BioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRC
Page Views
0
Share
Update Time
2022-10-03 11:30:04

"I love BioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRC"

www.biopronetuk.org VS www.gqak.com

2022-10-03 11:30:04

HomeAbout & ContactEvents & NewsSuccess StoriesCase StudiesEarly CareersJob OpportunitiesBioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRCBioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRCBioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRCBioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRCBioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRCBioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRCBioProNET - Network in Bioprocessing, a BBSRC NIBB co-sponsored by EPSRC#pb_slideshow_rslider-1.nivoSlider { overflow: visible !important;}#pb_slideshow_rslider-1 .nivo-prevNav, #pb_slideshow_rslider-1 .nivo-nextNav { background: #fff; color: #88969e; padding: 3px 8px; font-size: 16px; text-decoration: none !important; -webkit-transition: all .2s linear; -moz-transition: all .2s linear 0s; -webkit-opacity: .8; -moz-opacity: .8; opacity: .8;}#pb_slideshow_rslider-1 .nivo-prevNav:hover, #pb_slideshow_rslider-1 .nivo-nextNav:hover { color: #4f595f; -webkit-opacity: 1; -moz-opacity: 1; opacity: 1;}#pb_slideshow_rslider-1 .nivo-prevNav, #pb_slideshow_rslider-1 .nivo-nextNav { border: 1px solid #ebebeb; -webkit-border-radius: 3px; -moz-border-radius: 3px; border-radius: 3px; -webkit-box-shadow: 0 1px 7px rgba(0,0,0,0.2); -moz-box-shadow: 0 1px 7px rgba(0,0,0,0.2); box-shadow: 0 1px 7px rgba(0,0,0,0.2);}#pb_slideshow_rslider-1 .nivo-prevNav { left: 5px !important;}#pb_slideshow_rslider-1 .nivo-nextNav { right: 5px !important;}#pb_slideshow_rslider-container-1 .nivo-control img { background: #fff; padding: 3px; border: 1px solid #dedede; border-radius: 2px; -webkit-transition: all .2s linear; -moz-transition: all .2s linear 0s; -webkit-opacity: .5; -moz-opacity: .5; opacity: .5;}#pb_slideshow_rslider-container-1 .nivo-control img:hover, #pb_slideshow_rslider-container-1.nivo-control.active img { -webkit-opacity: 1; -moz-opacity: 1; opacity: 1;}@media only screen and ( max-width:480px ) {#pb_slideshow_rslider-1 .nivo-prevNav { margin-left: -20px !important;}#pb_slideshow_rslider-1 .nivo-nextNav { margin-right: -20px;}}#pb_slideshow_rslider-1 .nivo-imageLink { background: white !important;filter: alpha(opacity=0) !important;opacity: 0 !important;}HomeBioProNET2 – 9th Annual Science MeetingGSK, Gunnels Wood Road, Stevenage, October 11th-12th 2022LAST CHANCE TO REGISTER !!BioProNET2 Annual Science meeting returns to a face-to-face format this year. In addition to invited oral presentations from key industrial and academic groups, there will also be poster sessions with plenty of time for networking.Sessions include:Early Careers Session (Oct 11th – 11:00-12:30)Cell Engineering (Oct 11th – 13:00-14:30)Cell culture and process control (Oct 11th – 16:00-17:30)Heterogeneity is the essence of manufacture (Oct 12th – 09:00-10:30)QbD for analytics (Oct 12th – 11:30-13:00)10 years from now – what does the future hold (Oct 12th – 13:45-15:15)Three dedicated poster viewing sessions SEE THE FULL PROGRAMME AND YOU CAN REGISTER HERE NOW !!Registration to attend the meeting is £100 (non-refundable) and this covers your attendance at the science meeting (and the ECR workshop, if applicable) as well as refreshments and lunches each day. The meeting drinks reception/dinner will be held on the evening of October 11th with an additional cost of £50.Please note that registration will close once all places (150) are taken, or 30th September (whichever is earlier).LINK to hotels nearby should you require accommodation  SAVE THE DATE – 26-29 June 2022Registration is open https://esact2022.com/index.php/welcome32nd Annual ESACT-UK Meeting on January 5th – 6th 2022.The meeting is virtual and registration is FREE. For more information  please go to www.esactuk.org.ukBioProNET2 Annual Meeting 2021BioProNET2 is an academic-industry networking club sponsored by industry, who together with a group of academics aim to maintain and develop the community that was brought together so successfully by BioProNET.This years’ symposium will be virtual, covering the entire range of production and manufacture of biological modalities (expression-process-analytics). Presentations will be delivered in short sessions, starting at 14:00 on the afternoon of November 8th and finishing at 13:20 on November 9th.  The event is FREE to attend and you can REGISTERHERE.Day 1 – November 8thSession 1: Vaccines/viral vectors, 14.00-15.20Session 2: Emerging product classes in bioprocessing, 15.30-16.50Day 2 – November 9thSession 1: Novel protein format therapeutics, 09.00-10.20Session 2: Products fit for function, 10.30-11.50Session 3: Cell-free production/systems, 12.00-13.20 Speakers include:Cath Green (Jenner Institute, University of Oxford)Qasim Rafiq (UCL), Carol Knevelman (Oxford Biomedica)Randolf Cortelling (Evox)Yuval Elani (Imperial College London)Ashley Buckle (Monash University)David Beal (University of Kent)Alex MacPherson (UCB)Nico Callewaert (Ghent University)Ian Anderson (Pharmaron)Noel Smith (Lonza)Karen Polizzi (Imperial College London)Colin Barker (BiologIC Technologies)Trevor Hallam (Sutro)Hold the date: BioProNET2 Annual Science ConferenceNovember, 8th & 9th 2021This year’s conference will again be held in virtual format and we are currently finalising a great programme of talks.Themes to be covered will include:Products fit for functionNew therapeutic entitiesCell-free productionVaccines/viral vectorsNovel protein format therapeuticsBBSRC Networks help Holiferm turn greentech breakthrough into growing business29 Apr 2021University of Manchester spinout Holiferm is justifiably upbeat about the future. Its novel method for making a key ingredient of everyday household products avoids fossil fuel-based feedstocks. The resulting ingredient is both biodegradable and low in ecotoxicity – opening pathways to major global markets. It’s taken just eight years to get here, driven by the energy and ingenuity of PhD student Ben Dolman and his supervisor Dr James Winterburn. BBSRC Networks in Industrial Biotechnology and Bioenergy (NIBB) helped them develop contacts that proved crucial to this classic clean-growth success story, which now includes a strategic agreement with one of the world’s biggest chemical producers.Key impactsInnovative lower-cost process for turning renewable feedstocks into biodegradable surfactants successfully brought to market.The NIBB provided targeted support at critical points in the emergence of Holiferm, the spinout created from the breakthrough.Over £1 million of investment already secured in the company.Rapidly growing workforce, with 14 full-time equivalent (FTE) jobs and rising at the Manchester/Daresbury-based firm.Holiferm set to reach industrial-scale production capacity in 2022, providing a significant, environmentally friendly boost to decarbonisation of the chemicals sector.Full story can be found on BBSRC website https://bbsrc.ukri.org/research/impact/bbsrc-networks-help-holiferm-turn-greentech-breakthrough-into-growing-business/ESACT-UK 2021 – Registration open – FREE to attendRegistration is now open for the 31st ESACT UK annual conference taking place virtually on 6/7 January and is FREE for all members HEREProgramme includes presentations on topics such as Covid-19 & vaccine manufacture, antibody bioprocessing and advanced therapies.  Speakers include –Paul Kellam, Kymab LtdSandy Douglas, University of OxfordMartin Smith, VMICFelicity Rose, University of NottinghamJames Budge, University of KentIvan Wall, Aston UniversityJohn Pieracci, BiogenBioProNET2, 7th Annual Scientific MeetingNovember 19/20 2020This years’ symposium will be virtual, covering the entire range of production and manufacture of biological modalities (expression-process-analytics).  Presentations will be delivered in short sessions, starting on the afternoon of November 19th and throughout November 20th. A short poster session will run on November 20th.The meeting is free to attend and you can register HEREFULL PROGRAMMEThursday November 19th      Bioprocessing perspectives for COVID-19 (14.00- 15:50)Antu Dey (IAVI)Paul Davis (Mologic Ltd)Robin Shattock (Imperial College London) Simon Carding (Quadram Institute)Friday November 20thGood analytics make or break the process  (09.30- 11:00)         Marc Olivier Baradez (Cell & Gene Therapy Catapult)Liz Topp (NIBRT/Purdue)James Wilkinson (Refeyn Ltd) Poster session (11:00-12:00)Full list HEREThe process quality defines the product (12:45- 14:00)Anurag Rathore (IIT Delhi) Tibor Nagy (Fujifilm Diosynth) Biosynthologies) Franscesc Godia (UAB, Barcelona) Engineering cell factories to make products – (14:45-16:20)Govind Rao (University of Maryland) Mike Jewett (Northwestern University, Illinois) Velia Siciliano (IIT, Genova) Laura Segatori (Rice University, Texas) BioProNET2 is an academic-industry networking club sponsored by industry, who together with a group of academics aim to maintain and develop the community that was brought together so successfully by BioProNET.BioProNET2 Steering Group:Paul Dalby (UCL), Alan Dickson (University of Manchester), Jo Flannelly (University of Manchester), Cleo Kontoravdi (Imperial College), Mark Smales (University of Kent), Ivan Wall (Aston University).The steering group includes representatives of Allergan Biologics, AZ, Cell & Gene Therapy Catapult, Cobra Biologics, Fujifilm Diosynth Biotechnologies, GSK, Kymab, Lonza Biologics, Pall Corporation.Welcome to BioProNET2 – Academic – Industry NetworkBioProNET has evolved and returned as BioProNET2, an academic-industry networking club with sponsorship through a group of industrial and commercial colleagues who together with a group of academics (see below) aim to maintain and develop the community that was brought together so successfully by BioProNET. Our general objectives are to:mobilise a collaborative UK scientific community to address the challenges around, and enhance, the manufacture of emerging novel biological modalities.capitalise on entrepreneurship and address fundamental scientific challenges to enable robust and economically viable manufacture.develop a forum to engage academics and early career researchers with the industrial sector and entrepreneurial practitioners to provide a framework to train and inspire the next generation.As a starting point for the focus of BioProNET2 we will be running an annual scientific meeting and a series of subject-specific workshops throughout each year, which this year will have a virtual, on-line structure. You have previously been associated with, and/or attended, meetings organised by BioProNET and, at this stage, we wish to inform you of our general plans and ask you to indicate your interest in hearing about, and being involved in, future activities organised by BioProNET2. We hope that you will and would ask you to forward this communication to any colleagues who you would also think would be interested in being part of BioProNET2 activities.Just insert the appropriate heading and return this e-mail to the sending address:YES, please!! Let me know all about BioProNET2 activitiesNO, thank you, this is no longer appropriate for meWe are currently updating our BioProNET2 website so please check HERE and our Twitter feed for further information or please contact Jo FlannellyBioProNET2 Steering Group:Paul Dalby (UCL), Alan Dickson (University of Manchester), Jo Flannelly (University of Manchester), Cleo Kontoravdi (Imperial College), Mark Smales (University of Kent), Ivan Wall (Aston University). Current industrialists include representatives of Allergan Biologics, AZ, Cell & Gene Therapy Catapult, Cobra Biologics, Fujifilm Diosynth Biotechnologies, GSK, Kymab, Lonza Biologics, Pall Corporation.You might also be interested in the BBSRC phase II NIBB.SuccessesCase studies of how our funding and events has brought together members from academia and industry to work on innovative research can be found here.Read our interim achievement reportMember Profiles – read how BioProNET has helped members Charlie and Michael.Newsletters & reportsRead our latest newsletter here.Click here to read the BioProNET interim report – highlighting many of our achievements.Photos from BioProNET’s 2017 Science Meeting, taken by Linas TamosaitisBioProNET Latest NewsNational Horizons Centre (NHC) – job opportunitiesLonza – Senior/Lead Scientist – Molecular BiologyPostdoctoral Positions – Reimagining Protein Manufacturing, USABioProNET Latest TweetsTweets by @BioProNETUK BioProNET copyright © 2014 | Privacy & Cookies Policy Contact BioProNETThis website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More